SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
DYAX: Dyax Corp.
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
197 20 0 DYAX
Emcee:  SI (no user) Type:  Moderated
Introduction Market Data Compact
This message board is intended for discussion of DYAX: Dyax Corp..
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
197oooops, wrong thread.scaram(o)uche-2/5/2018
196Down just a bit after hours on news of an offering. Should be interesting, feelscaram(o)uche-8/8/2017
1956:32AM Dyax and Sigma-Tau announce partnership to develop and commercialize subcmlkr-6/21/2010
194<i>>They'd better stick to what they know best - antibiotics.<&lDewDiligence_on_SI-4/1/2010
193They'd better stick to what they know best - antibiotics.idos-4/1/2010
192Cubist's track record with inlicensing has been atrocious.rkrw-4/1/2010
191It was no big surprised if even I could see it coming back in Dec: siliconinvesidos-4/1/2010
1901K shares of it were hanging on arca at about the close for a few minutes after scaram(o)uche-3/31/2010
189>>Cubist Pharmaceuticals to End Development of CB-500,929 Decision followstuck-3/31/2010
188CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX - News) announced todnigel bates-12/2/2009
187CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX - News) announced tonigel bates-10/13/2009
186>>Dyax Receives Complete Response Letter from FDA for DX-88 in Acute Attactuck-3/26/2009
185DYAX said in its Q4 CC that the focus of their discussions with FDA is a "sidos-2/25/2009
184Dyax Announces Expansion of Antibody Discovery Collaboration with Biogen Idec Thnigel bates-2/5/2009
183Panel voted 6-5 (2 abstentions) to approve. They voted (8-5) that the drug is efidos-2/5/2009
182Yes or no vote? First notice from ScotTrade said this had failed on a 5 to 6 voSteve Lokness-2/4/2009
181Cinryze was approved as an orphan drug for prophylactic treatment of HAE and sinidos-11/23/2008
180Hasn't Lev already beat them to market and attained the orphan exclusivity? mcbio-11/22/2008
179FDA has accepted for filing the BLA for DX-88 (ecallantide) for the treatment ofidos-11/21/2008
178Dyax announced completion of BLA for DX-88 for HAE and has requested Priority Reidos-9/24/2008
177DX-88 has successfully completed EDEMA4 trial. No allergic reactions were found.idos-8/18/2008
176GENZ once owned half the rights to this program but relinquished them to Dyax foDewDiligence_on_SI-4/25/2008
175<i>Thought I'd mention Jerini's whiff, though, since no one else hDewDiligence_on_SI-4/24/2008
174Maybe the market is negative because Dyax reported a net loss of $21.3M, ended Qidos-4/24/2008
173Delidos-4/24/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News